Market Overview
Vitiligo
Treatment Market is projected to achieve a value of USD 1,593 Million in 2023,
with a linear behavior in the market growth and is forecasted to achieve a
value of USD 2,601 Million by 2033 with a CAGR of 6.50% during the forecast
period 2023-2033.
Vitiligo
is a disease that causes an extensive loss of pigmentation in the human skin.
This is due to When pigment-producing cells die or not working properly or stop
working, vitiligo develops. A few body parts that might suffer from loss of
skin color like, mouth, hair, palms, neck, and eyes. It results from the lack
of skin pigment called melanin. The melanin is a pigment which made by
melanocytes, which are skin cells, imparts color to the skin.
Vitiligo
Treatment is a rapidly growing market, because of now a day’s various treatment
options are available to help manage the symptoms and improve the appearance of
the affected areas to lighten the unaffected areas of the skin to match the
depigmented patches. This growth is being driven by a number of factors,
including the high prevalence of vitiligo in elder patients, the genetic and
neurological factor, increasing disease awareness, and easy availability of
medications.
However,
there are some challenges that need to be addressed in order to make Vitiligo
Treatment more accessible to a wider range of users. High cost of medication,
poor development in healthcare infrastructure are some challenges in Vitiligo
Treatment. Additionally, complication involve like psychological distress, sunburn,
hair loss, eye problem will act as restrain to growth of the vitiligo treatment
Market.
Market Scope
Report Attributes |
Description |
Market Size in 2022 |
USD
1,500 Million |
Market Forecast in 2033 |
USD 2,601
Million |
CAGR % 2023-2033 |
6.50% |
Base Year |
2022 |
Historic Data |
2016-2022 |
Forecast Period |
2023-2033 |
Report USP |
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
Segments Covered |
Type,
Treatment Type, End-User |
Growth Drivers |
Ongoing
research in dermatology and autoimmune diseases has led to a better
understanding of the underlying mechanisms of vitiligo. Growing cosmetic concerns among the people The vitiligo treatment pipeline is promising, with several novel therapies and biologics in development |
Regional Scope |
North
America, Europe, APAC, South America and Middle East and Africa |
Country Scope |
U.S.;
Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries;
Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand;
Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies |
Novartis
AG,Allergan Inc., Clinuvel Pharmaceuticals Limited, Astellas Pharma Inc.,
Bausch Health Companies Inc., STRATA Skin Sciences, Reddy's Laboratories
Ltd., Eli Lilly Company, Incyte Corporation. |
Market Dynamics
The
Vitiligo Treatment market is driven by increasing number prevalence of
Vitiligo, increasing development in healthcare infrastructure, increasing
investment in research and developments, positive results of clinical trials.
The
increasing prevalence of vitiligo is estimated to increase the market's growth,
by rate ranges between 0.2% and 4%. Vitiligo is a hypopigmentation skin
condition in which the skin colour is lost due to a lack of melanin in the skin
cells. It also affects hair and all portions of the body's skin and inside of
the mouth. Vitiligo is neither life-threatening nor communicable its only related
with the skin color.
The
large patients pool infected by the Vitiligo. It shown that the need for
advance and approved treatment option drive the growth of Vitiligo market.
Currently there is no any treatment option for Vitiligo in developed or developing
markets. For instance, according to the American Academy of Dermatology (AAD),
an estimated 84.5 million, or one in four Americans, suffer from vitiligo.
Also,
in the present vitiligo treatment options, there need to be more effective
treatment options, which can offer to relapse of vitiligo in the patches of
skin previously treated. Now a day there is a growing interest in natural drugs
and products like, herbal drugs or products, vitamins and herbs extracts in the
treatment of Vitiligo, which provides a boost for the overall vitiligo
treatment market.
Overall,
with the help of existing and combination treatment therapy the vitiligo drugs
market is expected to witness significant growth in the coming years, driven by
the introduction of new therapies and an increasing demand for effective
treatments. Additionally, there is a need for advance and effective research
and development to address the unmet needs of vitiligo treatment and to develop
safe and effective therapies with lower side effects.
Market Type Analysis
By
type, the Vitiligo Treatment market is Categories into Non-Segmental Vitiligo,
Segmental Vitiligo. The Non-Segmental Vitiligo segment accounts for the largest
share of around 57% of the market in 2022.
The
segment dominated the market because rise in the patient diagnosed with
non-segmental vitiligo. The segment is forecast is a growing segment because of
the awareness about the symptoms and causes of vitiligo.
Market Treatment Type Analysis
By
type, the Vitiligo Treatment market is Categories into Topical Treatment, Light
Therapy, Surgical Procedures, Others. The Topical Treatment segment accounts
for the largest share of around 43% of the market in 2022.
The
Topical Treatment segment dominates the market because it is most widely use
and preferred treatment option due to its easy availability. Additionally, by
avoiding internal organ system such as GIT, liver, kidney. It also avoids the
major side effect, bioavailability and other issues. Topical treatment is the
fine choice treatment to treat Vitiligo.
Market End-user Analysis
By
End-user, the Vitiligo Treatment market is Categories into Hospitals and Aesthetic
Clinics. The Hospital segment accounts for the largest share of around 56% of
the market in 2022. Rising investment in healthcare and increasing hospital
facility in developed and developing country are major factor to drive the
segment.
Moreover,
Hospitals are the primary healthcare facility where patient come for treatment
Vitiligo, especially when the condition is severe or widespread.
However,
Aesthetic Clinics in developing countries are anticipated to drive the Vitiligo
Treatment market. Patient in initial level or less awareness about vitiligo are
drive this segment. It because clinics are the easy and convenient to
reach.
Market Regional Analysis
North
America dominate the Vitiligo Treatment market with the highest revenue
generating market with share of more than 43%. The North American dominate this
market due to the easy availability of medications, increased awareness of
disease and the rise in vitiligo in adults. Moreover, the increasing number of
established health clubs and fitness facilities will boost the market growth in
this Region.
Europe
having the second-largest market share in Vitiligo Treatment market due to the
rising acceptance of cutting-edge technology and increased advance surgical techniques
by key market players. Moreover, the UK market was the fastest-growing market
and the German market held the largest market share, in the European Region
Asia-Pacific
is estimated the fastest growing CAGR in Vitiligo market in forecasted period. This
is due to increasing in healthcare expenditure and the rise in research and
development activities in the pharmaceutical sector.
Competitive Analysis
The
Vitiligo Treatment market is dominated by a few large companies, such as Novartis
AG,Allergan Inc., Clinuvel Pharmaceuticals Limited, Astellas Pharma Inc.,
Bausch Health Companies Inc., STRATA Skin Sciences, Reddy's Laboratories Ltd.,
Eli Lilly Company, Incyte Corporation.
There
are some of the recent developments of the market:
April
2022 a Strategic Alliance Agreement for the development is announced by Incyte
and Maruho Co., Ltd., manufacturing, and exclusive commercialization of
ruxolitinib cream, a novel cream formulation of Incyte’s selective JAK2
inhibitor ruxolitinib, in Japan for the treatment of autoimmune and inflammatory
dermatology indications.
March 2022 STRATA Skin Sciences, a medical technology company dedicated to developing, commercializing, and marketing innovative products for treating various autoimmune skin diseases, announced that it had joined the Vitiligo Foundation as a corporate sponsor (GVF).
By Type
·
Non-segmental Vitiligo
·
Segmental Vitilig
By Treatment Type
·
Topical Treatment,
·
Light Therapy,
·
Surgical Procedures,
·
Others
By End-user
·
Hospitals
· Aesthetic Clinics
1.
Global
Oncology Drugs Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Oncology Drugs Market
Scope and Market Estimation
1.2.1. Global Oncology Drugs Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2033)
1.2.2. Global Oncology Drugs Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033
1.3. Market Segmentation
1.3.1. Component of Global Oncology
Drugs Market
1.3.2. Technology of Global Oncology
Drugs Market
1.3.3. End-user of Global Oncology
Drugs Market
1.3.4. Region of Global Oncology Drugs
Market
2.
Executive Summary
2.1. Global Oncology Drugs Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Oncology Drugs Market
Industry Development
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6. Value Chain / Ecosystem Analysis
2.7. Russia-Ukraine War Impacts
Analysis
2.8. Economic Downturn Analysis
2.9. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.
Global Oncology Drugs Market Estimates & Historical Trend Analysis (2019 -
2022)
4.
Global Oncology Drugs Market Estimates & Forecast Trend Analysis, Drug
Class Type
4.1. Global Oncology Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, Drug Class Type, 2019 to 2033
4.1.1. Chemotherapy
4.1.2. Targeted Therapy
4.1.3. Immunotherapy (Biologic Therapy)
4.1.4. Hormonal Therapy
5.
Global Oncology Drugs Market Estimates & Forecast Trend Analysis, by
Indication
5.1. Global Oncology Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Indication, 2019 to 2033
5.1.1. Lung Cancer
5.1.2. Stomach Cancer
5.1.3. Colorectal Cancer
5.1.4. Breast Cancer
5.1.5. Prostate Cancer
5.1.6. Liver Cancer
5.1.7. Esophagus Cancer
5.1.8. Cervical Cancer
5.1.9. Kidney Cancer
5.1.10. Bladder Cancer
5.1.11. Other Cancers
6.
Global Oncology Drugs Market Estimates & Forecast Trend Analysis, by
End-user
6.1. Global Oncology Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by End-user,
2019 to 2033
6.1.1. Hospital Pharmacies
6.1.2. Retail Pharmacies
6.1.3. Online Pharmacies
7.
Global Oncology Drugs Market Estimates & Forecast Trend Analysis,
by Region
7.1. Global Oncology Drugs Market
Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2033
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Middle East & Africa
7.1.5. South America
8.
North
America Oncology Drugs Market: Estimates & Forecast Trend Analysis
8.1.
North
America Oncology Drugs Market Assessments & Key Findings
8.1.1. North America Oncology Drugs
Market Introduction
8.1.2. North America Oncology Drugs
Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
8.1.2.1. Drug Class Type
8.1.2.2. By Indication
8.1.2.3. By End-user
8.1.2.4. By Country
8.1.2.4.1. The U.S.
8.1.2.4.2. Canada
8.1.2.4.3. Mexico
9.
Europe
Oncology Drugs Market: Estimates & Forecast Trend Analysis
9.1. Europe Oncology Drugs Market
Assessments & Key Findings
9.1.1. Europe Oncology Drugs Market
Introduction
9.1.2. Europe Oncology Drugs Market
Size Estimates and Forecast (US$ Million) (2019 – 2033)
9.1.2.1. Drug Class Type
9.1.2.2. By Indication
9.1.2.3. By End-user
9.1.2.4.
By
Country
9.1.2.4.1. Germany
9.1.2.4.2. U.K.
9.1.2.4.3. France
9.1.2.4.4. Italy
9.1.2.4.5. Spain
9.1.2.4.6. Russia
9.1.2.4.7. Rest of Europe
10. Asia Pacific Oncology
Drugs Market: Estimates & Forecast
Trend Analysis
10.1. Asia Pacific Market Assessments
& Key Findings
10.1.1. Asia Pacific Oncology Drugs
Market Introduction
10.1.2. Asia Pacific Oncology Drugs
Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
10.1.2.1. Drug Class Type
10.1.2.2. By Indication
10.1.2.3. By End-user
10.1.2.4. By Country
10.1.2.4.1. China
10.1.2.4.2. Japan
10.1.2.4.3. India
10.1.2.4.4. Australia
10.1.2.4.5. South Korea
10.1.2.4.6. ASEAN
10.1.2.4.7. Rest of Asia Pacific
11. Middle East & Africa Oncology
Drugs Market: Estimates & Forecast
Trend Analysis
11.1. Middle East & Africa Market
Assessments & Key Findings
11.1.1. Middle
East & Africa Oncology
Drugs Market Introduction
11.1.2. Middle
East & Africa Oncology
Drugs Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
11.1.2.1. Drug Class Type
11.1.2.2. By Indication
11.1.2.3. By End-user
11.1.2.4. By Country
11.1.2.4.1. U.A.E.
11.1.2.4.2. Saudi Arabia
11.1.2.4.3. Egypt
11.1.2.4.4. South Africa
11.1.2.4.5. Rest of Middle East & Africa
12. South America
Oncology Drugs Market: Estimates &
Forecast Trend Analysis
12.1. South America Market Assessments
& Key Findings
12.1.1. South America Oncology Drugs
Market Introduction
12.1.2. South America Oncology Drugs
Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
12.1.2.1. Drug Class Type
12.1.2.2. By Indication
12.1.2.3. By End-user
12.1.2.4. By Country
12.1.2.4.1. Brazil
12.1.2.4.2. Argentina
12.1.2.4.3. Colombia
12.1.2.4.4. Rest of South America
13. Competition Landscape
13.1. Global Oncology Drugs Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
13.2. Global Oncology Drugs Market
Competition White Space Analysis, By End-user
13.3. Global Oncology Drugs Market
Competition Heat Map Analysis, By End-user
13.4. Global Oncology Drugs Market
Concentration & Company Market Shares (%) Analysis, 2022
14. Company Profiles
14.1.
Merck & co., inc.
14.1.1. Company Overview & Key Stats
14.1.2. Financial Performance & KPIs
14.1.3. Product Portfolio
14.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
15.
Novartis International Ag
16.
Amgen, Inc.
17.
Bristol-Myers Squibb Company
18.
Astrazeneca Plc
19.
F. Hoffmann-La Roche Ag
20.
Pfizer, Inc.
21.
Astellas Pharma Inc.
22. Johnson & Johnson,
Abbvie Inc.
23. Research
Methodology
23.1. External Transportations /
Databases
23.2. Internal Proprietary Database
23.3. Primary Research
23.4. Secondary Research
23.5. Assumptions
23.6. Limitations
23.7. Report FAQs
24. Research Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Vitiligo Treatment market was valued at USD 1,500 million in 2022 and is estimated to grow at a CAGR of 6.50%.
Novartis AG,Allergan Inc., Clinuvel Pharmaceuticals Limited, Astellas Pharma Inc., Bausch Health Companies Inc., STRATA Skin Sciences, Reddy's Laboratories Ltd., Eli Lilly Company, Incyte Corporation.
North America dominates the market with an active share of 43%, while North America is estimated to grow at a higher CAGR of 11%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar